‘Competition drives better service, better product, better quality’: Bernard Lord on why a single-payer model of pharmacare would harm patient choice and innovation

Bernard Lord, former premier of New Brunswick and current CEO of Medavie Blue Cross, joins Hub Dialogues to discuss the Trudeau government’s pharmacare legislation, the benefits of Canada’s current mixed model of drug insurance, the difference between single-payer and universality, and how to build on the strengths of the current system to provide drug coverage to those who need it.

This episode was made possible by the Canadian Life and Health Insurance Association and listeners like you.